Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte

Clinical trial NCT07427576 · COMPLETED

Trial details

NCT number: NCT07427576
Sponsor: Inmunotek S.L.
Status: COMPLETED
Study type: OBSERVATIONAL

Mite Allergy Dermatophagoides Farinae Allergy Dermatophagoides Pteronyssinus Allergy Rhinitis, Allergic Asthma Rhinoconjunctivitis

Start date: 2025-03-31
Primary completion: 2025-08-31
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.